drugset / Trial / NCT02637284
PCO-02 - Safety and Pharmacokinetics Trial
RandomizedParallel-groupQuadruple-blindBasic science
Summary
Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source.
Timeline
- Start
- 2015-10
- Primary completion
- 2016-02
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BPC 157 | Protein / enzyme biologic | 1 mg | Oral |
| Subject | BPC 157 | Protein / enzyme biologic | 3 mg | Oral |
| Subject | BPC 157 | Protein / enzyme biologic | 6 mg | Oral |
Indications
No indication recorded.